Quick Answer
ATOSSA THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $41.30 million for the year ending 2025.
- ATOSSA THERAPEUTICS, INC. showed a decrease of -41.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ATOSSA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $41.30 million | Fiscal year 2024: $71.08 million | Fiscal year 2023: $88.46 million | Fiscal year 2022: $110.89 million | Fiscal year 2021: $136.38 million | Fiscal year 2020: $39.55 million | Fiscal year 2019: $12.58 million | Fiscal year 2018: $10.38 million | Fiscal year 2017: $7.22 million | Fiscal year 2016: $3.03 million | Fiscal year 2015: $3.72 million | Fiscal year 2014: $8.50 million | Fiscal year 2013: $6.34 million | Fiscal year 2012: $1.73 million | Fiscal year 2011: $1.91 million | Fiscal year 2010: $10.3 thousand | Fiscal year 2009: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: